Physician profile
Robert T Howard
NPI 1669457487
$3,537.30
in general payments reported to CMS, 2019-2025
14 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $66.78 · 2021: $243 · 2022: $937 · 2023: $342 · 2024: $809 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,200.30 | 2023-2025 | |
| Allergan, INC. | $836.92 | 2020-2022 | |
| Mentor Worldwide LLC | $442.41 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $331.27 | 2024-2025 | Tisseel, Preveleak, Perclot |
| Integra Lifesciences Corporation | $289.54 | 2021-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Axogen | $121.43 | 2022 | |
| Motiva USA, LLC | $92.21 | 2025 | |
| Sientra, INC. | $47.68 | 2022 | |
| Ethicon US, LLC | $39.52 | 2025 | Vistaseal |
| Stryker Corporation | $35.94 | 2025 | Spy-Phi System |
| Revance Therapeutics, INC. | $35.62 | 2024 | Daxxify |
| Tela Bio, INC. | $33.23 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.48 | 2024 | Exparel |
| Innovation Technologies INC | $13.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.